A hybrid multiscale model for predicting CAR-T therapy outcomes in solid tumors

Mohammad R Nikmaneshi1, Lance L Munn2

  • 1Edwin L. Steele Laboratories, Department of Radiation Oncology, Harvard Medical School and Massachusetts General Hospital, Boston, MA, 02114, USA.

Scientific Reports
|May 23, 2026
PubMed

Insights

Understanding tumor microenvironment barriers is key for effective CAR-T cell immunotherapy. Our model shows collagen density and metabolic competition significantly impact T cell infiltration and tumor response.

Area of Science:

  • Immunology
  • Biomedical Engineering
  • Computational Biology

Background:

  • Tumor hotness, or T cell distribution within tumors, is crucial for immunotherapy success.
  • Current strategies to enhance T cell accumulation face limitations due to poor understanding of T cell-microenvironment interactions.

Purpose of the Study:

  • To develop a mechanistic physiological model of the 3D tumor microenvironment (TME).
  • To evaluate CAR-T cell performance under varying environmental conditions and infusion strategies.

Main Methods:

  • Integrated key vascular (rolling, adhesion, endothelial suppression) and interstitial (ECM density, metabolic competition, chemokine sensitivity) barriers into a 3D TME model.
  • Simulated CAR-T cell performance across different environmental fluctuations and infusion strategies.

Main Results:

  • Collagen density and metabolic competition were identified as dominant factors limiting CAR-T efficacy.
  • Enhanced vascular rolling and adhesion improved infiltration but were constrained by collagen and metabolism.
  • Endothelial suppression significantly reduced tumor hotness, while its alleviation improved response.
  • Systemic infusion led to higher tumor hotness than intratumoral delivery.

Conclusions:

  • Alleviating barriers like collagen density and metabolic competition can restore CAR-T efficacy.
  • Combined infusion routes or reduced collagen density can overcome limitations in dense tumors.
  • The developed mechanistic framework allows for rational optimization of CAR-T cell strategies.

Related Concept Videos